Stocks Screener

Specify Company / Ticker to Get the Summary

Internet Computer ICP
Bitcoin Cash BCH
Litecoin LTC
Field stub for analysis

Dividend History ADTX

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021

Dividend Analytics ADTX

Max Ratio

5Y Dividend Growth

Consecutive Years

5Y Average Payout Ratio

Forward Annual Dividend Yield
Consecutive Years
Forward Annual Dividend – USD
Consistent Years
Dividend CAGR 3Y
Continuous Dividends
Dividend CAGR 5Y
Payout Ratio TTM
Dividend CAGR 10Y
Ex Dividend Date

Aditxt Inc.

ADTX
Current price
1.20 USD -0.02 USD (-1.64%)
Last closed 1.22 USD
ISIN US0070251097
Sector Healthcare
Industry Biotechnology
Exchange NASDAQ
Capitalization 2 966 003 USD
Yield for 12 month -98.01 %
1Y
3Y
5Y
10Y
15Y
ADTX
21.11.2021 - 28.11.2021

Aditxt, Inc., a commercial-stage company, discovers and develops products in the areas of immune health, precision health, population health, women's health, and neurologic health. The company develops AditxtScore that enable individuals to understand, manage, and monitor their immune profiles in order to be informed about attacks on or by their immune system; and Apoptotic DNA Immunotherapy, a nucleic acid-based technology that utilizes an approach that mimics the way the body naturally induces tolerance to its tissues. It also develops ADI-100 for skin grafting, psoriasis, type 1 diabetes, and multiple sclerosis. Aditxt, Inc. has a license agreement with Loma Linda University and Leland Stanford Junior University. The company was formerly known as ADiTx Therapeutics, Inc. and changed its name to Aditxt, Inc. in July 2021. Aditxt, Inc. was incorporated in 2017 and is headquartered in Mountain View, California. Address: 2569 Wyandotte Street, Mountain View, CA, United States, 94043

Check your investment idea

Find the best to beat the market
TSLA TSLA Tesla Motors
AAPL AAPL Apple
MSFT MSFT Microsoft

Analytics

WallStreet Target Price

61.00 USD

P/E Ratio

Dividend Yield

Financials ADTX

1 year
3 years
5 years
10 years
15 years
Results 2019 Dynamics
* The data for this period has not yet been published

Key Figures ADTX

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021

Current Year

+133 985 USD

Last Year

+645 176 USD

Current Quarter

+1 018 USD

Last Quarter

+3 175 USD

Current Year

-493 000 USD

Last Year

-112 000 USD

Current Quarter

+284 USD

Last Quarter

-67 830 USD
EBITDA -21 396 732 USD
Operating Margin TTM -550 895.36 %
Price to Earnings
Return On Assets TTM -46.32 %
PEG Ratio
Return On Equity TTM -204.37 %
Wall Street Target Price 61.00 USD
Revenue TTM 55 323 USD
Book Value 13.73 USD
Revenue Per Share TTM
Dividend Share
Quarterly Revenue Growth YOY -98.70 %
Dividend Yield
Gross Profit TTM -507 086 USD
Earnings per share -25.94 USD
Diluted Eps TTM -25.94 USD
Most Recent Quarter I 2025
Quarterly Earnings Growth YOY
Profit Margin

Stock Valuation ADTX

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
Forward PE 0.37
Enterprise Value Revenue 118.18
Price Sales TTM 53.61
Enterprise Value EBITDA 0.023
Price Book MRQ 0.18

Technical Indicators ADTX

For 52 Weeks

1.05 USD 27 200.00 USD
50 Day MA 1.58 USD
Shares Short Prior Month 24 484
200 Day MA 140.66 USD
Short Ratio 0.22
Shares Short 226 971
Short Percent 1.15 %